Zachary B. Myers
Partner
-
Comprehensive Corporate Experience
Zach advises clients across the full corporate lifecycle, representing venture-backed start-ups, emerging growth companies, and publicly traded corporations. His practice encompasses everything from formation and venture financings to IPOs, mergers, and complex public company transactions. He is known for guiding clients through high-value, strategically significant deals with a deep understanding of both private and public market dynamics.
-
Recognized Subject-Matter Expert
Zach is a respected authority and frequent speaker on corporate and securities law issues. He has presented at more than 100 venture and industry conferences and leading universities, sharing practical insights on topics spanning early-stage financing and governance through public offerings and ongoing public company compliance
Zachary B. Myers is widely recognized as one of Southern California’s top corporate attorneys for life sciences and technology companies. A partner in Wilson Sonsini’s San Diego office, Zach has over 15 years of experience as a go-to corporate lawyer for venture-backed start-ups, emerging growth companies, and publicly traded corporations navigating complex, high-value transactions.
Zach advises venture-backed companies, public companies, and venture capital firms on a wide range of corporate matters, including:
- Venture capital financings (seed, Series A, growth equity, and late-stage deals)
- Initial public offerings (IPOs) and public offerings
- Mergers and acquisitions (M&A) and strategic exits
- Post-IPO compliance and ongoing public company representation
- University spinouts and technology transfer from incubator programs
He is frequently sought out by life sciences and technology companies in California and nationwide that require sophisticated legal counsel across the full company lifecycle, from first-in funding rounds to late-stage financings, transformative IPOs, and strategic M&A transactions.
Zach was formerly an attorney with Sempra Energy and Pillsbury Winthrop Shaw Pittman LLP in San Diego. Prior to law school, Zach worked as an accountant in the audit department at Deloitte and Touche. Zach is a certified public accountant (inactive) licensed by the state of California.
Experience
Zachary B. Myers is widely recognized as one of Southern California’s top corporate attorneys for life sciences and technology companies. A partner in Wilson Sonsini’s San Diego office, Zach has over 15 years of experience as a go-to corporate lawyer for venture-backed start-ups, emerging growth companies, and publicly traded corporations navigating complex, high-value transactions.
Zach advises venture-backed companies, public companies, and venture capital firms on a wide range of corporate matters, including:
- Venture capital financings (seed, Series A, growth equity, and late-stage deals)
- Initial public offerings (IPOs) and public offerings
- Mergers and acquisitions (M&A) and strategic exits
- Post-IPO compliance and ongoing public company representation
- University spinouts and technology transfer from incubator programs
He is frequently sought out by life sciences and technology companies in California and nationwide that require sophisticated legal counsel across the full company lifecycle, from first-in funding rounds to late-stage financings, transformative IPOs, and strategic M&A transactions.
Zach was formerly an attorney with Sempra Energy and Pillsbury Winthrop Shaw Pittman LLP in San Diego. Prior to law school, Zach worked as an accountant in the audit department at Deloitte and Touche. Zach is a certified public accountant (inactive) licensed by the state of California.
Education
- J.D., University of San Diego School of LawCum Laude; Order of the Coif; Member, San Diego Law Review
- B.A., Economics, Claremont McKenna College
Associations and Memberships
- Member, Board of Directors, EvoNexus
- Member, Board of Directors, Connect (formerly known as San Diego Venture Group)
Honors
- Top Attorney, San Diego Metro Magazine (2026)
- Top Attorney, San Diego Metro Magazine (2024)
- Top 100 Leaders in Law, San Diego Business Journal (2023)
- 100 Top Attorneys, San Diego Business Journal (2022)
- Person of Influence, San Diego Metro Magazine (2022)
- Top Attorney, San Diego Metro Magazine (2021)
- 40 Next Top Business Leaders Under 40, San Diego Business Journal, Finalist (2021)
- San Diego Business Journal’s Leaders in Law, Finalist (2021)
- Top 40 Under 40, San Diego Metro Magazine (2020)
- Finalist, Leaders in Law, San Diego Business Journal (2020)
Admissions
- State Bar of California
Credentials
Education
- J.D., University of San Diego School of LawCum Laude; Order of the Coif; Member, San Diego Law Review
- B.A., Economics, Claremont McKenna College
Associations and Memberships
- Member, Board of Directors, EvoNexus
- Member, Board of Directors, Connect (formerly known as San Diego Venture Group)
Honors
- Top Attorney, San Diego Metro Magazine (2026)
- Top Attorney, San Diego Metro Magazine (2024)
- Top 100 Leaders in Law, San Diego Business Journal (2023)
- 100 Top Attorneys, San Diego Business Journal (2022)
- Person of Influence, San Diego Metro Magazine (2022)
- Top Attorney, San Diego Metro Magazine (2021)
- 40 Next Top Business Leaders Under 40, San Diego Business Journal, Finalist (2021)
- San Diego Business Journal’s Leaders in Law, Finalist (2021)
- Top 40 Under 40, San Diego Metro Magazine (2020)
- Finalist, Leaders in Law, San Diego Business Journal (2020)
Admissions
- State Bar of California
Select Transactions
Zach’s recent representative transactions include:
Public Offering and Capital Markets Transactions
- Represented a life sciences company in a $201.25 million underwritten public offering
- Represented a life sciences company in a $100.0 million at-the-market equity offering program
- Represented a life sciences company in a business combination with approximately $345.0 million in gross proceeds, including a $200.0 million PIPE investment
- Represented a life sciences company in a $60.0 million follow-on public offering
- Represented a life sciences company in a $201.3 million aggregate principal amount convertible senior notes issuance
- Represented a life sciences company in a $30.0 million at-the-market equity offering program
- Represented a life sciences company in a global option exchange
- Represented a life sciences company in a $125.0 million convertible senior notes exchange
- Represented a life sciences company in a $63.3 million underwritten follow-on public offering
- Represented a life sciences company in a $250.0 million strategic capital infusion, consisting of convertible preferred stock and convertible term loans
- Represented a medical technology company in its $70.6 million initial public offering
- Represented a medical technology company in a $51.9 million secondary public offering
- Represented a therapeutics company in its $50.0 million initial public offering
- Represented a therapeutics company in a $38.0 million follow-on public offering
- Represented a therapeutics company in a $10.8 million underwritten public offering
- Represented a life sciences company in a $441.0 million private exchange of convertible senior notes
- Represented a technology company in a $225.1 million modified Dutch auction share repurchase tender offer
- Represented a technology company in a $325.0 million modified Dutch auction share repurchase tender offer
M&A Transactions
- Represented a life sciences company in a $207.5 million acquisition transaction
- Represented a medical technology company in a $101.8 million acquisition of a medical device company
- Represented a medical technology company in the acquisition of an international medical technology business
- Represented a therapeutics company in a tender offer and merger valued at up to $515.5 million
- Represented a technology company in a $287.0 million cash-and-stock acquisition
- Represented a technology company in a $21.0 million cash acquisition of a business line
- Represented a technology company in an $80.0 million acquisition of assets and intellectual property
- Represented a technology company in a $21.0 million cash acquisition of a business
- Represented a technology company in an approximately $700.0 million cash-and-stock acquisition
- Represented a technology company in a $150.0 million all-cash asset acquisition of a business division
- Represented a life sciences company in a $50 million sale of assets
Matters
Select Transactions
Zach’s recent representative transactions include:
Public Offering and Capital Markets Transactions
- Represented a life sciences company in a $201.25 million underwritten public offering
- Represented a life sciences company in a $100.0 million at-the-market equity offering program
- Represented a life sciences company in a business combination with approximately $345.0 million in gross proceeds, including a $200.0 million PIPE investment
- Represented a life sciences company in a $60.0 million follow-on public offering
- Represented a life sciences company in a $201.3 million aggregate principal amount convertible senior notes issuance
- Represented a life sciences company in a $30.0 million at-the-market equity offering program
- Represented a life sciences company in a global option exchange
- Represented a life sciences company in a $125.0 million convertible senior notes exchange
- Represented a life sciences company in a $63.3 million underwritten follow-on public offering
- Represented a life sciences company in a $250.0 million strategic capital infusion, consisting of convertible preferred stock and convertible term loans
- Represented a medical technology company in its $70.6 million initial public offering
- Represented a medical technology company in a $51.9 million secondary public offering
- Represented a therapeutics company in its $50.0 million initial public offering
- Represented a therapeutics company in a $38.0 million follow-on public offering
- Represented a therapeutics company in a $10.8 million underwritten public offering
- Represented a life sciences company in a $441.0 million private exchange of convertible senior notes
- Represented a technology company in a $225.1 million modified Dutch auction share repurchase tender offer
- Represented a technology company in a $325.0 million modified Dutch auction share repurchase tender offer
M&A Transactions
- Represented a life sciences company in a $207.5 million acquisition transaction
- Represented a medical technology company in a $101.8 million acquisition of a medical device company
- Represented a medical technology company in the acquisition of an international medical technology business
- Represented a therapeutics company in a tender offer and merger valued at up to $515.5 million
- Represented a technology company in a $287.0 million cash-and-stock acquisition
- Represented a technology company in a $21.0 million cash acquisition of a business line
- Represented a technology company in an $80.0 million acquisition of assets and intellectual property
- Represented a technology company in a $21.0 million cash acquisition of a business
- Represented a technology company in an approximately $700.0 million cash-and-stock acquisition
- Represented a technology company in a $150.0 million all-cash asset acquisition of a business division
- Represented a life sciences company in a $50 million sale of assets
Select Speaking Engagements
- Panelist, “Designing Your Board of Directors,” Advance Conference, September 19, 2025
- Presenter, “Company Creation Seminar for Venture-Backed Startups,” Stanford Labs, August 6, 2025
- Presenter, “Series A Financing- Strategies to Succeed,” Liquid 2 Ventures, San Francisco, CA, July 20, 2025
- Speaker, “Corporate and Intellectual Property Bootcamp,” UCSD Jacobs School of Engineering, April 17, 2025
- Presenter, “Forming and Organizing the Startup Entity,” April 10, 2025,
- Speaker, “Financing Trends-Series A through IPO,” ARE Gradlabs, April 8, 2025,
- Presenter, “Advanced Term Sheet Seminar,” UCSD Rady School of Business, April 1, 2025
- Moderator, “Venture-Backed Founders- How I Raised my Series A,” Homelab/Nucleate, March 20, 2025
- Presenter, “Intro to US Expansion for Global Companies,” March 19, 2025
- Presenter, “Term Sheet Negotiation,” Venture Fellow Summit, January 23, 2025
- Speaker, “Financing High Growth Startups,” Rady School of Management, UC San Diego, May 8, 2024
- Presenter, Forming and Financing Life Sciences Startups, Homelab Accelerator, April 18, 2024
- Speaker, “SD Activator Workshop: Corporate and IP Strategy,” Nucleate, February 26, 2024
- Lecturer, Organizing and Financing University Startups, San Diego State University, February 23, 2024
- Speaker, “Special Topics in Management: MedTech Financings,” University of California, Los Angeles, Anderson School of Management, February 20, 2024
- Speaker, “Corporate Law for Patent Attorneys,” Wilson University, December 4, 2023
- Speaker, “Corporate Fundamentals for Venture Backed Companies,” Institute for the Global Entrepreneur, November 28, 2023
- Speaker, “Financing and Capital Raising for Startups,” Institute for the Global Entrepreneur, October 24, 2023
- Presenter, “Term Sheet Seminar,” Rady Business School, UCSD, October 19, 2023
- Lecturer, Market Trends in Venture Financings, Rady Business School, UCSD, September 13, 2023
- Moderator, “Post-Covid Fundraising and Business Development Strategies,” EvoNexus, September 6, 2023
- Speaker, “Financial Reporting Fundamentals,” August 21, 2023
- Speaker, “Financing Space Technology Startups,” Amazon Web Services, May 22, 2023
- Speaker, “Trends in Life Science Financings,” University of California, San Diego, May 8, 2023
- Speaker, “Advanced Financing Strategies,” StartR Accelerator, April 19, 2023
- Speaker, “Financing for High Growth Companies,” Nucleate, April 4, 2023
- Lecturer, Lean Lecture Series: “Investor and Founder Term Sheet Negotiation," University of California, San Diego, March 9, 2023
- Speaker, “Legal Considerations for New Technology Businesses,” StartR Blue, Scripps Institute, February 22, 2023
- Lecturer, “Financing Trends in MedTech,” University of California, Los Angeles, February 21, 2023
- Speaker, “Growing Life Sciences Companies,” Health Innovation and Translation Symposium, February 11, 2023
- Speaker, “Corporate Law for Patent Lawyers,” December 12, 2022
- Speaker, “Startup Ventures,” UCSD Medical School, November 18, 2022
- Lecturer, “Forming and Organizing Venture-Backed Life Sciences Companies,” Rady School of Business, University of California, San Diego, October 25, 2022
- Lecturer, “Structuring Life Sciences Companies,” University of California, San Diego, October 20, 2022
- Presenter, “Forming and Organizing Life Sciences Companies,” Keck Graduate Institute, September 29, 2022
- Speaker, “Financing Space Technology Startups,” Amazon Web Services Space Technology Incubator, June 28, 2022
- Speaker, “Formation and Financing Trends and Strategies for Life Sciences Companies,” Keck Graduate Institute, March 24, 2022
- Lecturer, “Legal Strategies for the Emerging Growth MedTech Company,” University of California, Los Angeles, February 15, 2022
- Lecturer, “Advanced Venture Financings,” Rady School of Business, University of California, San Diego, May 4, 2022
- Speaker, “Corporate Planning and Fundraising for the Emerging Growth Company,” UCLA BioDesign, Anderson School of Business, April 24, 2022
- Lecturer, “Forming High Growth Startups,” Rady School of Business, University of California, San Diego, March 30, 2022
- Panelist, “Cap Tables and VC Term Sheets for Entrepreneurs,” Riverside Angel Summit, October 4, 2021
- Speaker, Corporate Law for Patent Lawyers, September 30, 2021
- Speaker, “Workshop for Startups -- Financing Trends and Strategies: Early Stage Financings,” First Look SoCal, June 16, 2021
- Speaker, “Incorporating, Financing Trends and Strategies,” University of California, San Diego, April 29, 2021
- Speaker, “Corporate Financing,” Drug Development & Product Management, Skaggs School of Pharmacy, UCSD, November, 2020
- Speaker, “Corporate Law and Business Development,” Drug Development & Product Management, Skaggs School of Pharmacy, UCSD, November, 2020
- Moderator, “Preparing for a Liquidity Event- How to Avoid Obstacles,” Octane OC MedTech Innovation Forum, October 30, 2020
- Speaker, “Trends in Early Stage VC Investing for Emerging Growth Startups,” First Look SoCal Innovation Showcase, September 16, 2020
- Speaker, Corporate Law for Patent Lawyers, July 13, 2020
- Speaker, “Corporate Finance,” Drug Development & Product Management, Skaggs School of Pharmacy, UCSD, April 22, 2020
- Speaker, “Corporate Law and Business Development,” Drug Development & Product Management, Skaggs School of Pharmacy, UCSD, April 15, 2020
- Panelist, "Trends in Executive and Board Compensation," Larger Than Life Science: LaunchBio, September 26, 2019
- Speaker, "Corporate Finance," UCSD Drug Development & Product Management, Skaggs School of Pharmacy, July 16, 2019
- Speaker, "Corporate Law and Business Development," UCSD Drug Development & Product Management, Skaggs School of Pharmacy, July 9, 2019
- Speaker, "Forming and Organizing a Corporate Entity/Business Plans," UC San Diego Entrepreneurship Series, January 17, 2019
- Speaker, "Venture Capital: Negotiations between Founders and Investors—How to Avoid Misunderstandings," Global Entrepreneurship and Innovation Seminar, November 10, 2018
- Presenter, "Essentials of Startup Law," Cal Poly, San Luis Obispo, November 2, 2018
- Presenter, "Organizing Companies for Venture Capital Financing," University of California, San Diego Kick-Off Bootcamp, October 17, 2018
- Speaker, "Venture Capital Term Sheets," Entrepreneurship Series, University of California, San Diego, February 8, 2018
- Presenter, "Venture Capital Financing and Trends," Entrepreneurship Series, University of California, San Diego, January 11, 2018
- Speaker, "Venture Capital Term Sheet Seminar," UCLA Bootcamp, University of California, Los Angeles, October 25, 2017
- Presenter, "Hiring and Compensating Employees," UC San Diego/WSGR Entrepreneurship Series, University of California, San Diego, June 8, 2017
- Speaker, "MedTech Innovation," UCLA Anderson School of Business, April 24, 2017
- Presenter, "Entrepreneurship Seminar Series," University of California, San Diego, March 9, 2017
- Speaker, "Technology and Life Sciences Bootcamp," University of California, Los Angeles, October 26, 2016
- Speaker, "Business Plans and Fundraising," University of California, San Diego, October 20, 2016
- Speaker, "Pitchbook Strategy Session," BIOCOM DeviceFest, July 28, 2016
- Speaker, "BioEngineering—MedTech Innovation," UCLA Anderson School of Business, May 16, 2016
- Speaker, UChicago Innovation Fest, May 14, 2016
- Speaker, Entrepreneur Workshop, The University of California, Irvine, April 22, 2016
- Speaker, Life Sciences Bootcamp, McCormick School of Engineering, Northwestern University, April 16, 2016
- Speaker, "Life Sciences Bootcamp," McCormick School of Engineering, Northwestern University, April 16, 2016
- Presenter, "Business Plans and Fundraising," University of California, Los Angeles, November 4, 2015
- Speaker, "Essentials of Startup Law," Northwestern University, October 12, 2015
Insights
Select Speaking Engagements
- Panelist, “Designing Your Board of Directors,” Advance Conference, September 19, 2025
- Presenter, “Company Creation Seminar for Venture-Backed Startups,” Stanford Labs, August 6, 2025
- Presenter, “Series A Financing- Strategies to Succeed,” Liquid 2 Ventures, San Francisco, CA, July 20, 2025
- Speaker, “Corporate and Intellectual Property Bootcamp,” UCSD Jacobs School of Engineering, April 17, 2025
- Presenter, “Forming and Organizing the Startup Entity,” April 10, 2025,
- Speaker, “Financing Trends-Series A through IPO,” ARE Gradlabs, April 8, 2025,
- Presenter, “Advanced Term Sheet Seminar,” UCSD Rady School of Business, April 1, 2025
- Moderator, “Venture-Backed Founders- How I Raised my Series A,” Homelab/Nucleate, March 20, 2025
- Presenter, “Intro to US Expansion for Global Companies,” March 19, 2025
- Presenter, “Term Sheet Negotiation,” Venture Fellow Summit, January 23, 2025
- Speaker, “Financing High Growth Startups,” Rady School of Management, UC San Diego, May 8, 2024
- Presenter, Forming and Financing Life Sciences Startups, Homelab Accelerator, April 18, 2024
- Speaker, “SD Activator Workshop: Corporate and IP Strategy,” Nucleate, February 26, 2024
- Lecturer, Organizing and Financing University Startups, San Diego State University, February 23, 2024
- Speaker, “Special Topics in Management: MedTech Financings,” University of California, Los Angeles, Anderson School of Management, February 20, 2024
- Speaker, “Corporate Law for Patent Attorneys,” Wilson University, December 4, 2023
- Speaker, “Corporate Fundamentals for Venture Backed Companies,” Institute for the Global Entrepreneur, November 28, 2023
- Speaker, “Financing and Capital Raising for Startups,” Institute for the Global Entrepreneur, October 24, 2023
- Presenter, “Term Sheet Seminar,” Rady Business School, UCSD, October 19, 2023
- Lecturer, Market Trends in Venture Financings, Rady Business School, UCSD, September 13, 2023
- Moderator, “Post-Covid Fundraising and Business Development Strategies,” EvoNexus, September 6, 2023
- Speaker, “Financial Reporting Fundamentals,” August 21, 2023
- Speaker, “Financing Space Technology Startups,” Amazon Web Services, May 22, 2023
- Speaker, “Trends in Life Science Financings,” University of California, San Diego, May 8, 2023
- Speaker, “Advanced Financing Strategies,” StartR Accelerator, April 19, 2023
- Speaker, “Financing for High Growth Companies,” Nucleate, April 4, 2023
- Lecturer, Lean Lecture Series: “Investor and Founder Term Sheet Negotiation," University of California, San Diego, March 9, 2023
- Speaker, “Legal Considerations for New Technology Businesses,” StartR Blue, Scripps Institute, February 22, 2023
- Lecturer, “Financing Trends in MedTech,” University of California, Los Angeles, February 21, 2023
- Speaker, “Growing Life Sciences Companies,” Health Innovation and Translation Symposium, February 11, 2023
- Speaker, “Corporate Law for Patent Lawyers,” December 12, 2022
- Speaker, “Startup Ventures,” UCSD Medical School, November 18, 2022
- Lecturer, “Forming and Organizing Venture-Backed Life Sciences Companies,” Rady School of Business, University of California, San Diego, October 25, 2022
- Lecturer, “Structuring Life Sciences Companies,” University of California, San Diego, October 20, 2022
- Presenter, “Forming and Organizing Life Sciences Companies,” Keck Graduate Institute, September 29, 2022
- Speaker, “Financing Space Technology Startups,” Amazon Web Services Space Technology Incubator, June 28, 2022
- Speaker, “Formation and Financing Trends and Strategies for Life Sciences Companies,” Keck Graduate Institute, March 24, 2022
- Lecturer, “Legal Strategies for the Emerging Growth MedTech Company,” University of California, Los Angeles, February 15, 2022
- Lecturer, “Advanced Venture Financings,” Rady School of Business, University of California, San Diego, May 4, 2022
- Speaker, “Corporate Planning and Fundraising for the Emerging Growth Company,” UCLA BioDesign, Anderson School of Business, April 24, 2022
- Lecturer, “Forming High Growth Startups,” Rady School of Business, University of California, San Diego, March 30, 2022
- Panelist, “Cap Tables and VC Term Sheets for Entrepreneurs,” Riverside Angel Summit, October 4, 2021
- Speaker, Corporate Law for Patent Lawyers, September 30, 2021
- Speaker, “Workshop for Startups -- Financing Trends and Strategies: Early Stage Financings,” First Look SoCal, June 16, 2021
- Speaker, “Incorporating, Financing Trends and Strategies,” University of California, San Diego, April 29, 2021
- Speaker, “Corporate Financing,” Drug Development & Product Management, Skaggs School of Pharmacy, UCSD, November, 2020
- Speaker, “Corporate Law and Business Development,” Drug Development & Product Management, Skaggs School of Pharmacy, UCSD, November, 2020
- Moderator, “Preparing for a Liquidity Event- How to Avoid Obstacles,” Octane OC MedTech Innovation Forum, October 30, 2020
- Speaker, “Trends in Early Stage VC Investing for Emerging Growth Startups,” First Look SoCal Innovation Showcase, September 16, 2020
- Speaker, Corporate Law for Patent Lawyers, July 13, 2020
- Speaker, “Corporate Finance,” Drug Development & Product Management, Skaggs School of Pharmacy, UCSD, April 22, 2020
- Speaker, “Corporate Law and Business Development,” Drug Development & Product Management, Skaggs School of Pharmacy, UCSD, April 15, 2020
- Panelist, "Trends in Executive and Board Compensation," Larger Than Life Science: LaunchBio, September 26, 2019
- Speaker, "Corporate Finance," UCSD Drug Development & Product Management, Skaggs School of Pharmacy, July 16, 2019
- Speaker, "Corporate Law and Business Development," UCSD Drug Development & Product Management, Skaggs School of Pharmacy, July 9, 2019
- Speaker, "Forming and Organizing a Corporate Entity/Business Plans," UC San Diego Entrepreneurship Series, January 17, 2019
- Speaker, "Venture Capital: Negotiations between Founders and Investors—How to Avoid Misunderstandings," Global Entrepreneurship and Innovation Seminar, November 10, 2018
- Presenter, "Essentials of Startup Law," Cal Poly, San Luis Obispo, November 2, 2018
- Presenter, "Organizing Companies for Venture Capital Financing," University of California, San Diego Kick-Off Bootcamp, October 17, 2018
- Speaker, "Venture Capital Term Sheets," Entrepreneurship Series, University of California, San Diego, February 8, 2018
- Presenter, "Venture Capital Financing and Trends," Entrepreneurship Series, University of California, San Diego, January 11, 2018
- Speaker, "Venture Capital Term Sheet Seminar," UCLA Bootcamp, University of California, Los Angeles, October 25, 2017
- Presenter, "Hiring and Compensating Employees," UC San Diego/WSGR Entrepreneurship Series, University of California, San Diego, June 8, 2017
- Speaker, "MedTech Innovation," UCLA Anderson School of Business, April 24, 2017
- Presenter, "Entrepreneurship Seminar Series," University of California, San Diego, March 9, 2017
- Speaker, "Technology and Life Sciences Bootcamp," University of California, Los Angeles, October 26, 2016
- Speaker, "Business Plans and Fundraising," University of California, San Diego, October 20, 2016
- Speaker, "Pitchbook Strategy Session," BIOCOM DeviceFest, July 28, 2016
- Speaker, "BioEngineering—MedTech Innovation," UCLA Anderson School of Business, May 16, 2016
- Speaker, UChicago Innovation Fest, May 14, 2016
- Speaker, Entrepreneur Workshop, The University of California, Irvine, April 22, 2016
- Speaker, Life Sciences Bootcamp, McCormick School of Engineering, Northwestern University, April 16, 2016
- Speaker, "Life Sciences Bootcamp," McCormick School of Engineering, Northwestern University, April 16, 2016
- Presenter, "Business Plans and Fundraising," University of California, Los Angeles, November 4, 2015
- Speaker, "Essentials of Startup Law," Northwestern University, October 12, 2015
Recent Insights
Client Highlights
Wilson Sonsini Advises PacBio on Sale of Short-Read DNA Sequencing Assets
On February 2, 2026, PacBio, a leading developer of high-quality, highly accurate sequencing solutions, announced the completion of the sale of select intellectual property and other assets related to PacBio’s short-read DNA sequencing technology and related clustering, sequencing reagent, and detection technologies to Illumina, Inc. PacBio received approximately $50 million in cash proceeds from the transaction. Wilson Sonsini Goodrich & Rosati advised PacBio on the transaction.
Learn More
Client Highlights
Wilson Sonsini Advises Iambic on Oversubscribed $100 Million Financing
On November 10, 2025, Iambic, a clinical-stage life science and technology company developing novel medicines using its AI-driven discovery and development platform, announced that it has raised approximately $100 million in an oversubscribed financing round. Wilson Sonsini Goodrich & Rosati advised Iambic on the transaction.
Learn More
Recent Events
Affiliated Programs
Legal Bootcamp for Startups: Integrating Discovery, Entrepreneurship and Advancement for Success
Wilson Sonsini is pleased to partner with UC San Diego to host the Legal Bootcamp for Startups: Integrating Discovery, Entrepreneurship and Advancement for Success half-day program designed for those in the process of—or considering—starting a new venture. Learn from our featured speakers as they cover topics ranging from corporate formation and financing to intellectual property and patent strategies. Immediately following this event, partake in a networking lunch and directly engage with our presenters and attendees.
Learn More
- Privacy Policy
- Terms of Use
- Accessibility
Copyright © 2026 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.